Fierce Biotech

  1. A new target in multiple myeloma? TAK1 blocker boosts chemo's cancer-killing power in preclinical study arlene.weintraub Mon, 10/18/2021 - 09:31
  2. FDA rejects Omeros transplant drug over difficulties estimating its effect ntaylor Mon, 10/18/2021 - 07:57
  3. Biogen's ALS drug has failed phase 3. Will FDA approve anyway? ntaylor Mon, 10/18/2021 - 05:13
  4. Greenwood takes the top job at Kojin Therapeutics, leading an all-woman biotech C-suite badams Fri, 10/15/2021 - 10:02
  5. Inhalable anti-COVID-19 antibody from TFF and Augmenta tamps down viral load in hamsters arlene.weintraub Fri, 10/15/2021 - 08:26